|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's range||56.60 - 57.94|
|52-week range||55.07 - 127.20|
|Beta (5Y monthly)||0.91|
|PE ratio (TTM)||10.44|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
LOS ANGELES, Jun 20, 2021--DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc.
LOS ANGELES, Jun 19, 2021--MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc.
NEW YORK, Jun 17, 2021--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. ("Emergent" or "the Company") (NYSE: EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between July 6, 2020 and March 31, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgan